Unintended consequences of co-payment regulations in Belgium: the case of atorvastatin

• Jessica Fraeyman,
• Hans De Loof,
• Guido Van Hal,
• Guido De Meyer,
• Roy Remmen,
• Philippe Beutels

Affiliations

Jessica Fraeyman

Department of Epidemiology and Social Medicine, Research Unit of Medical Sociology and Health Policy,University of Antwerp, Antwerp, 2610, Belgium.

Hans De Loof

Division of Physiopharmacology,University of Antwerp, Antwerp, 2610, Belgium.

Guido Van Hal

Department of Epidemiology and Social Medicine, Research Unit of Medical Sociology and Health Policy,University of Antwerp, Antwerp, 2610, Belgium.

Guido De Meyer

Division of Physiopharmacology,University of Antwerp, Antwerp, 2610, Belgium.

Roy Remmen

Department of Primary and Interdisciplinary Care,University of Antwerp, Antwerp, 2610, Belgium.

Philippe Beutels

Centre for Health Economics Research and Modelling Infectious Diseases (CHERMID),Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, 2610, Belgium.